Long-Acting Progestin Injectables

Ronna Jurow, Donna Shoupe
In: The Handbook of Contraception · 2006 · pp. 101–115 · doi:10.1007/978-1-59745-150-5_7 · W145430127
book-chapter OA: closed CC0
View on OpenAlex View at publisher

Abstract

Depo-Provera® (depot medroxyprogesterone acetate [DMPA]) is an extremely effective contraceptive agent. Since its introduction into the market in the 1960s, DMPA has been used for a variety of gynecological conditions including endometriosis and abnormal menstrual bleeding. For many years, DMPA was also commonly used “off-label“ as a contraceptive agent, especially in women who were not candidates for oral contraceptive (OC) pills. In 1992, the Food and Drug Administration (FDA) approved the marketing of DMPA as a contraceptive agent.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (46)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK